(i) Discuss the indications and methods of second-trimester termination of pregnancy.
(ii) Describe the medico-legal issues of mid-trimester medical termination of pregnancy in modern practice.
15 marks · directive: Discuss and describe
The core of a good answer
Second-trimester termination is permitted on grounds of risk to the woman, foetal anomalies, rape or incest, contraceptive failure and the special categories of the MTP (Amendment) Act, 2021, and is done medically with mifepristone followed by misoprostol; the medico-legal framework sets gestation-based opinion requirements (one RMP up to 20 weeks, two RMPs for special categories from 20 to 24 weeks, a Medical Board beyond 24 weeks only for foetal anomalies), consent, confidentiality, approved places, POCSO reporting for minors and the PC&PNDT controls on sex determination.
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
Part (i) (8 marks) needs indications grouped under the Act's grounds and the methods. Part (ii) (7 marks) needs the provisions of the MTP Act and Rules and related law (POCSO, PCPNDT), and recent judgments.
Answer outline
Introduction
The Medical Termination of Pregnancy Act, 1971 was amended in 2021 (in force from 24 September 2021), raising the upper limit for special categories to 24 weeks and allowing termination beyond 24 weeks for foetal anomalies on a Medical Board's decision.
(i) Indications
- Risk to the woman's life or of grave injury to her physical or mental health.
- Substantial foetal anomalies.
- Pregnancy from rape or incest (the Supreme Court in 2022 linked this ground to marital rape); failure of contraception, now available to unmarried women as well.
- Special categories for 20 to 24 weeks: survivors of sexual assault, rape or incest; minors; change of marital status during pregnancy (widowhood, divorce); women with physical disabilities; mentally ill women; foetal malformation; humanitarian, disaster or emergency settings.
(i) Methods
- Medical: mifepristone followed by misoprostol.
- Common steps: confirm gestation by ultrasound, check haemoglobin and blood group, and give post-abortion contraception and counselling.
(ii) Medico-legal issues
- Who and where: only a registered medical practitioner with a recognised qualification, entry in the State Medical Register and the required experience in obstetrics and gynaecology, at a government facility or a private place approved by the District Level Committee.
- Opinions: one RMP up to 20 weeks, two RMPs for 20 to 24 weeks, a State Medical Board for foetal anomalies beyond 24 weeks (decision within 3 days, procedure within 5 days).
- Consent: only the woman's own consent for adults; the guardian's consent for minors and mentally ill women.
- Minors: POCSO makes reporting mandatory, and failure to report can lead to imprisonment or a fine.
- Confidentiality: breach is punishable with imprisonment of up to a year, a fine, or both.
- Sex selection: the PC&PNDT Act regulates the misuse of diagnostic techniques to determine foetal sex.
- Court petitions for termination beyond legal limits, and the 2022 Supreme Court ruling that unmarried women have the same access up to 24 weeks as married women.
Conclusion
Mid-trimester termination is safe when done by trained providers by recommended methods, and lawful when the Act's conditions on opinion, consent, place and confidentiality are met.
Facts to remember
- MTP (Amendment) Act, 2021 came into force on 24 September 2021.
- Up to 20 weeks: opinion of one RMP; 20 to 24 weeks: two RMPs, for special categories; beyond 24 weeks: State Medical Board, for foetal anomalies.
- The contraceptive failure ground now extends to unmarried women.
- Medical Boards must decide within 3 days and carry out the procedure within 5 days.
- Supreme Court, Civil Appeal No. 5802 of 2022 (29 September 2022): only the woman's consent is material for adults; treating unmarried women differently is discriminatory.